scholarly journals Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach

2018 ◽  
Vol 29 (12) ◽  
pp. 2313-2327 ◽  
Author(s):  
R. Galot ◽  
C. Le Tourneau ◽  
J. Guigay ◽  
L. Licitra ◽  
I. Tinhofer ◽  
...  
2019 ◽  
Vol 21 (11) ◽  
Author(s):  
Eliane Tang ◽  
Lucien Lahmi ◽  
Nicolas Meillan ◽  
Gianandrea Pietta ◽  
Sébastien Albert ◽  
...  

2011 ◽  
Vol 2 (2) ◽  
pp. 161
Author(s):  
Anastasios N. Kanatas ◽  
Andrew T. Harris ◽  
Michael Messenger ◽  
David Houghton ◽  
Simon N. Rogers

The recurrence of a tumour at the resection margins in head and neck squamous cell carcinoma (HNSCC) has profound implications on the morbidity and mortality of the patient. At present HNSCC does not undergo any form of molecular analysis to aid treatment strategy and prognosticate for those individuals at higher risk of recurrence. This article aims to review current research into molecular strategies for tumour evaluation, highlighting conflicting evidence and possible novel concepts for further exploration.


Sign in / Sign up

Export Citation Format

Share Document